Long-term Efficacy and Tolerability of Adjunctive Aripiprazole for Major Depressive Disorder: Systematic Review and Meta-analysis
Clicks: 122
ID: 274324
2021
Given the scarcity of data, the authors of this review systematically synthesized the literature to determine the long-term efficacy and safety of aripiprazole as a maintenance augmenting agent for major depressive disorder. Read on to find out more.
| Reference Key |
seshadri2021thelong-term
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Ashok Seshadri;Michaela E. Wermers;Timothy J. Habermann;Balwinder Singh; |
| Journal | The primary care companion for CNS disorders |
| Year | 2021 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.